Sleep apnea is a breathing disorder where breathing repeatedly stops and starts. The brain tries to protect you by waking you up enough to breathe, but this prevents restful, healthy sleep. Over time, this condition can cause serious complications. However, this condition is often very manageable, especially with close adherence to prescribed treatments. There are three types of sleep apnea; obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. Obstructive sleep apnea is the most common type. Sleep apnea diagnostic systems include polysomnography (PSG) devices, screening devices, and actigraphy monitoring devices. Polysomnography is a sleep test used to diagnose various sleep disorders. The device is used to record brain waves, the oxygen level in the blood, heart rate and breathing, as well as eye and leg movements.
Market Dynamics
In recent years, home sleep tests have advanced significantly, and they are now widely used to diagnose sleep problems in the right patients. Thus, key market players are focusing on research and development activities and getting product approvals from the regulatory authorities, which is attributed to the growth of the global sleep apnea diagnostic system market. For instance, in February 2023, Sunrise, a sleep science company that develops a certified medical device for the diagnosis of sleep apnea, announced the U.S. Food and Drug Administration (FDA) had cleared for use its second-generation at-home sleep apnea test that uses artificial intelligence (AI) to aid in the diagnosis of obstructive sleep apnea and sleep-related breathing disorders. The Sunrise team is using a novel way to measure sleep through the bio-signal of Mandibular Jaw Movements (MJM), which has been studied for decades.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook